-
1
-
-
1842368507
-
-
Maloney 1997 Blood 90 2188
-
(1997)
Blood
, vol.90
, pp. 2188
-
-
Maloney1
-
3
-
-
44949245117
-
-
Dalakas 2008 Neurology 70 2252
-
(2008)
Neurology
, vol.70
, pp. 2252
-
-
Dalakas1
-
5
-
-
44949174084
-
-
Obermeier 2008 Nat Med 14 688
-
(2008)
Nat Med
, vol.14
, pp. 688
-
-
Obermeier1
-
6
-
-
0034961389
-
-
Derfuss 2001 Brain 124 1325
-
(2001)
Brain
, vol.124
, pp. 1325
-
-
Derfuss1
-
10
-
-
34249700046
-
-
Magliozzi 2007 Brain 130 1089
-
(2007)
Brain
, vol.130
, pp. 1089
-
-
Magliozzi1
-
12
-
-
44949253997
-
-
Krumbholz 2008 Brain 131 1455
-
(2008)
Brain
, vol.131
, pp. 1455
-
-
Krumbholz1
-
14
-
-
0024334648
-
-
Linington 1989 Brain 112 895
-
(1989)
Brain
, vol.112
, pp. 895
-
-
Linington1
-
17
-
-
33847677762
-
-
Kuhle 2007 J Neurol 254 160
-
(2007)
J Neurol
, vol.254
, pp. 160
-
-
Kuhle1
-
18
-
-
60349132403
-
Conformational serum anti-myelin antibodies are not associated with preclinical phase of MS
-
Chan A, Zhou D, Franke C et al (2008) Conformational serum anti-myelin antibodies are not associated with preclinical phase of MS. Neurology 70 [Suppl 1]:A379
-
(2008)
Neurology
, vol.70
, Issue.SUPPL. 1
-
-
Chan, A.1
Zhou, D.2
Franke, C.3
-
19
-
-
33846997877
-
-
O
-
O 2007 Nat Med 13 211
-
(2007)
Nat Med
, vol.13
, pp. 211
-
-
-
21
-
-
23944444890
-
-
Lennon 2005 J Exp Med 202 473
-
(2005)
J Exp Med
, vol.202
, pp. 473
-
-
Lennon1
-
24
-
-
0038523790
-
-
Bettelli 2003 J Exp Med 197 1073
-
(2003)
J Exp Med
, vol.197
, pp. 1073
-
-
Bettelli1
-
26
-
-
3242885605
-
Impact of neutralizing antibodies on the clinical efficacy of interferon beta in multiple sclerosis
-
Vartanian T, Solberg SP, Rice G (2004) Impact of neutralizing antibodies on the clinical efficacy of interferon beta in multiple sclerosis. J Neurol 251 [Suppl 2]:II25-II30
-
(2004)
J Neurol
, vol.251
, Issue.SUPPL. 2
-
-
Vartanian, T.1
Solberg, S.P.2
Rice, G.3
-
28
-
-
0027168420
-
-
Bubien 1993 J Cell Biol 121 1121
-
(1993)
J Cell Biol
, vol.121
, pp. 1121
-
-
Bubien1
-
30
-
-
0042346042
-
-
Di 2003 J Immunol 171 1581
-
(2003)
J Immunol
, vol.171
, pp. 1581
-
-
Di1
-
32
-
-
0035888030
-
-
Takemura 2001 J Immunol 167 4710
-
(2001)
J Immunol
, vol.167
, pp. 4710
-
-
Takemura1
-
34
-
-
60349083727
-
Pharmacokinetics and pharmacodynamics of rituximab in adults with relapsing remitting multiple sclerosis (RRMS) in a 48-week phase II placebo controlled multicenter trial
-
Bar-Or A, Waubant E, Ren S et al (2008) Pharmacokinetics and pharmacodynamics of rituximab in adults with relapsing remitting multiple sclerosis (RRMS) in a 48-week phase II placebo controlled multicenter trial. Neurology 70 [Suppl 1]:A226
-
(2008)
Neurology
, vol.70
, Issue.SUPPL. 1
-
-
Bar-Or, A.1
Waubant, E.2
Ren, S.3
-
35
-
-
19944427673
-
-
Gong 2005 J Immunol 174 817
-
(2005)
J Immunol
, vol.174
, pp. 817
-
-
Gong1
-
36
-
-
60349086735
-
Anti-CD20 mediated B-cell depletion reverses EAE induced by MOG protein, but exacerbates disease induced by its encephalitogenic peptide
-
Weber M, Prod'homme T, Karnezis T et al (2008) Anti-CD20 mediated B-cell depletion reverses EAE induced by MOG protein, but exacerbates disease induced by its encephalitogenic peptide. Neurology 68 [Suppl 1]:A339
-
(2008)
Neurology
, vol.68
, Issue.SUPPL. 1
-
-
Weber, M.1
Prod'homme, T.2
Karnezis, T.3
-
40
-
-
0034940417
-
-
D
-
D 2001 Arthritis Rheum 44 1717
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1717
-
-
-
42
-
-
23044516178
-
-
Voog 2003 N Engl J Med 348 2691
-
(2003)
N Engl J Med
, vol.348
, pp. 2691
-
-
Voog1
-
46
-
-
0142023105
-
-
Saito 2003 Lupus 12 798
-
(2003)
Lupus
, vol.12
, pp. 798
-
-
Saito1
-
50
-
-
17144426976
-
-
Sommer 2005 Lancet 365 1406
-
(2005)
Lancet
, vol.365
, pp. 1406
-
-
Sommer1
-
51
-
-
0016755254
-
-
Toyka 1975 Science 190 397
-
(1975)
Science
, vol.190
, pp. 397
-
-
Toyka1
-
53
-
-
0034633654
-
-
Zaja 2000 Neurology 55 1062
-
(2000)
Neurology
, vol.55
, pp. 1062
-
-
Zaja1
-
54
-
-
0344874207
-
-
Wylam 2003 J Pediatr 143 674
-
(2003)
J Pediatr
, vol.143
, pp. 674
-
-
Wylam1
-
55
-
-
33645328823
-
-
Hain 2006 Muscle Nerve 33 575
-
(2006)
Muscle Nerve
, vol.33
, pp. 575
-
-
Hain1
-
56
-
-
36348975152
-
-
Chan 2007 J Neurol 254 1604
-
(2007)
J Neurol
, vol.254
, pp. 1604
-
-
Chan1
-
58
-
-
10444237417
-
-
Ruegg 2004 Neurology 63 2178
-
(2004)
Neurology
, vol.63
, pp. 2178
-
-
Ruegg1
-
59
-
-
33645846637
-
-
Renaud 2006 Neurology 66 742
-
(2006)
Neurology
, vol.66
, pp. 742
-
-
Renaud1
-
65
-
-
10344250945
-
-
Lennon 2004 Lancet 364 2106
-
(2004)
Lancet
, vol.364
, pp. 2106
-
-
Lennon1
-
66
-
-
16844366404
-
-
Cree 2005 Neurology 64 1270
-
(2005)
Neurology
, vol.64
, pp. 1270
-
-
Cree1
-
69
-
-
26444598492
-
-
Stuve 2005 Arch Neurol 62 1620
-
(2005)
Arch Neurol
, vol.62
, pp. 1620
-
-
Stuve1
-
71
-
-
41849116363
-
-
Bar-Or 2008 Ann Neurol 63 395
-
(2008)
Ann Neurol
, vol.63
, pp. 395
-
-
Bar-Or1
-
74
-
-
17944375043
-
-
Gross 2001 Immunity 15 289
-
(2001)
Immunity
, vol.15
, pp. 289
-
-
Gross1
|